|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: WASATCH PHARMACEUTICAL INC, 10QSB, 2000-11-14 |
Next: WASATCH PHARMACEUTICAL INC, 10QSB, EX-28, 2000-11-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 105,280
<SECURITIES> 0
<RECEIVABLES> 51,107
<ALLOWANCES> 0
<INVENTORY> 7,179
<CURRENT-ASSETS> 279,149
<PP&E> 62,231
<DEPRECIATION> 41,706
<TOTAL-ASSETS> 489,421
<CURRENT-LIABILITIES> 3,862,134
<BONDS> 0
0
49
<COMMON> 20,766
<OTHER-SE> 3,236,419
<TOTAL-LIABILITY-AND-EQUITY> 484,421
<SALES> 16,044
<TOTAL-REVENUES> 20,901
<CGS> 3,267
<TOTAL-COSTS> 238,226
<OTHER-EXPENSES> 806,003
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 211,885
<INCOME-PRETAX> (1,235,214)
<INCOME-TAX> 0
<INCOME-CONTINUING> (1,235,214)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,235,214)
<EPS-BASIC> (.085)
<EPS-DILUTED> (.085)
</TABLE>
|
|